SEC 13F Intelligence

Farallon Capital Management, L.L.C. / TEVA

Farallon Capital Management, L.L.C.’s Teva Pharmaceutical Inds Ltd Position

Does Farallon Capital Management, L.L.C. own Teva Pharmaceutical Inds Ltd (TEVA)? Yes354.0K shares worth $11M (+0.06% of its 13F portfolio) as of Q1 2026, up from 40.0K shares the prior filed quarter.

Position Value
$11M
Q1 2026
Shares
354.0K
% of Portfolio
+0.06%
Quarters Held
3
currently held

Position History TEVA

Reported value by quarter
Q3 ’25: $101MQ3 ’25Q4 ’25: $1MQ4 ’25Q1 ’26: $11MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026354.0K$11M+0.06%
Q4 202540.0K$1M+0.01%
Q3 20255.00M$101M+0.41%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Farallon Capital Management, L.L.C.’s full portfolio or all institutional holders of TEVA.